{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:36:01Z","timestamp":1790030161255,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T00:00:00Z","timestamp":1644451200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012781","name":"MSD K.K.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jiac.2021.11.019","type":"journal-article","created":{"date-parts":[[2021,12,15]],"date-time":"2021-12-15T18:58:38Z","timestamp":1639594718000},"page":"406-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy and safety of daptomycin in Japanese pediatric participants with complicated skin and soft tissue infections or bacteremia caused by gram-positive cocci"],"prefix":"10.1016","volume":"28","author":[{"given":"Satoshi","family":"Iwata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9709-6170","authenticated-orcid":false,"given":"Hayato","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2021.11.019_bib1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12879-019-4033-0","article-title":"Molecular characteristics and clinical features of pediatric methicillin-susceptible Staphylococcus aureus infection in a medical center in northern Taiwan","volume":"19","author":"Chen","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2021.11.019_bib2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S2352-4642(18)30113-5","article-title":"Life-threatening infections in children in Europe (the EUCLIDS Project): a prospective cohort study","volume":"2","author":"Martin\u00f3n-Torres","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jiac.2021.11.019_bib3","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1017\/ice.2018.259","article-title":"Epidemiology of Staphylococcus aureus infections in patients admitted to freestanding pediatric hospitals, 2009-2016","volume":"39","author":"Spaulding","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jiac.2021.11.019_bib4","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/ofid\/ofy270","article-title":"Twenty-year trends in antimicrobial susceptibilities among Staphylococcus aureus from the SENTRY antimicrobial surveillance program","volume":"6","author":"Diekema","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2021.11.019_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jiac.2017.05.006","article-title":"The first nationwide surveillance of antibacterial susceptibility patterns of pathogens isolated from skin and soft-tissue infections in dermatology departments in Japan","volume":"23","author":"Watanabe","year":"2017","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2021.11.019_bib6","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10156-012-0423-6","article-title":"Methicillin-resistant Staphylococcus aureus bacteremia at a university hospital in Japan","volume":"18","author":"Isobe","year":"2012","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2021.11.019_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179767","article-title":"Estimating the disease burden of methicillin-resistant Staphylococcus aureus in Japan: retrospective database study of Japanese hospitals","volume":"12","author":"Uematsu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2021.11.019_bib8","series-title":"Annual open report 2019","year":"2020"},{"issue":"Suppl 4","key":"10.1016\/j.jiac.2021.11.019_bib9","first-page":"iv23","article-title":"Clinical experience with linezolid in infants and children","volume":"66","author":"Garazzino","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2021.11.019_bib10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jpeds.2010.08.019","article-title":"Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children","volume":"158","author":"McKamy","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.jiac.2021.11.019_bib11","series-title":"Prescribing information","year":"2017"},{"key":"10.1016\/j.jiac.2021.11.019_bib12","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jiac.2021.11.019_bib13","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2021.11.019_bib15","series-title":"Prescribing information","year":"2020"},{"key":"10.1016\/j.jiac.2021.11.019_bib16","series-title":"Cubicin 350 and 500 mg, Summary of Product Characteristics","year":"2010"},{"key":"10.1016\/j.jiac.2021.11.019_bib17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10156-012-0501-9","article-title":"Efficacy and safety of intravenous daptomycin in Japanese patients with skin and soft tissue infections","volume":"19","author":"Aikawa","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2021.11.019_bib18","series-title":"Japan prescribing information","year":"2011"},{"key":"10.1016\/j.jiac.2021.11.019_bib19","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/INF.0000000000001926","article-title":"Randomized multicenter study comparing safety and efficacy of daptomycin versus standard-of-care in pediatric patients with staphylococcal bacteremia","volume":"37","author":"Arrieta","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jiac.2021.11.019_bib20","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2477","article-title":"Daptomycin for complicated skin infections: a randomized trial","volume":"139","author":"Bradley","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.jiac.2021.11.019_bib21","series-title":"Guideline for clinical evaluation of antibacterial drugs","year":"2017"},{"key":"10.1016\/j.jiac.2021.11.019_bib22","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2018"},{"key":"10.1016\/j.jiac.2021.11.019_bib23","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard","year":"2018"},{"key":"10.1016\/j.jiac.2021.11.019_bib24","series-title":"Guidance for industry: general clinical pharmacology considerations for pediatric studies for drugs and biological products","year":"2014"},{"key":"10.1016\/j.jiac.2021.11.019_bib25","series-title":"Reflection paper on the use of extrapolation in the development of medicines for paediatrics","year":"2018"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21003305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21003305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:03:09Z","timestamp":1761159789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X21003305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1341321X21003305"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2021.11.019","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of daptomycin in Japanese pediatric participants with complicated skin and soft tissue infections or bacteremia caused by gram-positive cocci","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2021.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA and The Author(s). Published by Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases on behalf of Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}